Trial ID or NCT#



not recruiting iconNOT RECRUITING


Tweet2Quit is an innovative smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging. In a three-group randomized controlled trial, the investigators will compare: 1) usual care, 2) Tweet2Quit-coed, and 3) Tweet2Quit-Women only.

Official Title

Social Media Technology for Treating Tobacco Addiction

Eligibility Criteria

Ages Eligible for Study: 21 Years to 59 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes


Judith Prochaska
Senior Associate Vice Provost, Clinical Research Governance and Professor of Medicine (Stanford Prevention Research Center)

Contact us to find out if this trial is right for you.


Judith J Prochaska, PhD, MPH
(650) 724-3608